Package 61442-113-01

{"route": ["ORAL"], "spl_id": "209d3251-8d40-86dc-e063-6394a90a3492", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197311", "197313"], "spl_set_id": ["a68e610a-841c-4b69-9233-673d060561e8"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Carlsbad Technology, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "24 BOTTLE, PLASTIC in 1 BOX (61442-113-01)  / 100 TABLET in 1 BOTTLE, PLASTIC", "package_ndc": "61442-113-01", "marketing_start_date": "20200124"}, {"sample": false, "description": "12 BOTTLE, PLASTIC in 1 BOX (61442-113-05)  / 500 TABLET in 1 BOTTLE, PLASTIC", "package_ndc": "61442-113-05", "marketing_start_date": "20200124"}], "brand_name": "Acyclovir", "product_id": "61442-113_209d3251-8d40-86dc-e063-6394a90a3492", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "61442-113", "generic_name": "Acyclovir", "labeler_name": "Carlsbad Technology, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "800 mg/1"}], "application_number": "ANDA075382", "marketing_category": "ANDA", "marketing_start_date": "20091022", "listing_expiration_date": "20261231"}